Skip to main content
Top
Published in: Diabetology & Metabolic Syndrome 1/2012

Open Access 01-12-2012 | Short report

Undercarboxylated osteocalcin does not correlate with insulin resistance as assessed by euglycemic hyperinsulinemic clamp technique in patients with type 2 diabetes mellitus

Authors: Katsuhito Mori, Masanori Emoto, Koka Motoyama, Eiko Lee, Shinsuke Yamada, Tomoaki Morioka, Yasuo Imanishi, Tetsuo Shoji, Masaaki Inaba

Published in: Diabetology & Metabolic Syndrome | Issue 1/2012

Login to get access

Abstract

Background

Recent in vitro and in vivo studies have suggested a critical role of osteocalcin (OC), especially the undercarboxylated form (ucOC), in insulin secretion and insulin sensitivity. The objective of this study was to investigate the association between serum ucOC levels and insulin resistance in humans with type 2 diabetes mellitus.

Findings

We measured serum ucOC levels in 129 patients with type 2 diabetes. Insulin resistance was assessed using the euglycemic hyperinsulinemic clamp technique. The insulin resistance indices used were the M value, which is the total body glucose disposal rate, and the M/I value, which is the M value adjusted for the steady state plasma insulin level. ucOC levels were not correlated with the M value (ρ = −0.013, p = 0.886) or the M/I value (ρ = 0.001, p = 0.995).

Conclusions

We found no association between ucOC levels and insulin resistance in patients with type 2 diabetes mellitus.
Appendix
Available only for authorised users
Literature
1.
2.
go back to reference Ng KW: Regulation of glucose metabolism and the skeleton. Clin Endocrinol. 2011, 75: 147-155. 10.1111/j.1365-2265.2011.04133.x.CrossRef Ng KW: Regulation of glucose metabolism and the skeleton. Clin Endocrinol. 2011, 75: 147-155. 10.1111/j.1365-2265.2011.04133.x.CrossRef
3.
go back to reference Lee NK, Sowa H, Hinoi E, Ferron M, Ahn JD, Confavreux C, Dacquin R, Mee PJ, McKee MD, Jung DY, Zhang Z, Kim JK, Mauvais-Jarvis F, Ducy P, Karsenty G: Endocrine regulation of energy metabolism by the skeleton. Cell. 2007, 130: 456-469. 10.1016/j.cell.2007.05.047.PubMedCentralCrossRefPubMed Lee NK, Sowa H, Hinoi E, Ferron M, Ahn JD, Confavreux C, Dacquin R, Mee PJ, McKee MD, Jung DY, Zhang Z, Kim JK, Mauvais-Jarvis F, Ducy P, Karsenty G: Endocrine regulation of energy metabolism by the skeleton. Cell. 2007, 130: 456-469. 10.1016/j.cell.2007.05.047.PubMedCentralCrossRefPubMed
4.
go back to reference Ferron M, Hinoi E, Karsenty G, Ducy P: Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proc Natl Acad Sci. 2008, 105: 5266-5270. 10.1073/pnas.0711119105.PubMedCentralCrossRefPubMed Ferron M, Hinoi E, Karsenty G, Ducy P: Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proc Natl Acad Sci. 2008, 105: 5266-5270. 10.1073/pnas.0711119105.PubMedCentralCrossRefPubMed
5.
go back to reference Ferron M, McKee MD, Levine RL, Ducy P, Karsenty G: Intermittent injections of osteocalcin improve glucose metabolism and prevent type 2 diabetes in mice. Bone. 2012, 50: 568-575. 10.1016/j.bone.2011.04.017.PubMedCentralCrossRefPubMed Ferron M, McKee MD, Levine RL, Ducy P, Karsenty G: Intermittent injections of osteocalcin improve glucose metabolism and prevent type 2 diabetes in mice. Bone. 2012, 50: 568-575. 10.1016/j.bone.2011.04.017.PubMedCentralCrossRefPubMed
6.
go back to reference Kanazawa I, Yamaguchi T, Yamauchi M, Yamamoto M, Kurioka S, Yano S, Sugimoto T: Serum undercarboxylated osteocalcin was inversely associated with plasma glucose level and fat mass in type 2 diabetes mellitus. Osteoporosis Int. 2011, 22: 187-194. 10.1007/s00198-010-1184-7.CrossRef Kanazawa I, Yamaguchi T, Yamauchi M, Yamamoto M, Kurioka S, Yano S, Sugimoto T: Serum undercarboxylated osteocalcin was inversely associated with plasma glucose level and fat mass in type 2 diabetes mellitus. Osteoporosis Int. 2011, 22: 187-194. 10.1007/s00198-010-1184-7.CrossRef
7.
go back to reference Shea MK, Gundberg CM, Meigs JB, Dallal GE, Saltzman E, Yoshida M, Jacques PF, Booth SL: Gamma-carboxylation of osteocalcin and insulin resistance in older men and women. Am J Clin Nutr. 2009, 90: 1230-1235. 10.3945/ajcn.2009.28151.PubMedCentralCrossRefPubMed Shea MK, Gundberg CM, Meigs JB, Dallal GE, Saltzman E, Yoshida M, Jacques PF, Booth SL: Gamma-carboxylation of osteocalcin and insulin resistance in older men and women. Am J Clin Nutr. 2009, 90: 1230-1235. 10.3945/ajcn.2009.28151.PubMedCentralCrossRefPubMed
8.
go back to reference Iki M, Tamaki J, Fujita Y, Kouda K, Yura A, Kadowaki E, Sato Y, Moon JS, Tomioka K, Okamoto N, Kurumatani N: Serum undercarboxylated osteocalcin levels are inversely associated with glycemic status and insulin resistance in an elderly Japanese male population: Fujiwara-kyo Osteoporosis Risk in Men (FORMEN) Study. Osteoporosis Int. 2012, 23: 761-770. 10.1007/s00198-011-1600-7.CrossRef Iki M, Tamaki J, Fujita Y, Kouda K, Yura A, Kadowaki E, Sato Y, Moon JS, Tomioka K, Okamoto N, Kurumatani N: Serum undercarboxylated osteocalcin levels are inversely associated with glycemic status and insulin resistance in an elderly Japanese male population: Fujiwara-kyo Osteoporosis Risk in Men (FORMEN) Study. Osteoporosis Int. 2012, 23: 761-770. 10.1007/s00198-011-1600-7.CrossRef
9.
go back to reference Seino Y, Nanjo K, Tajima N, Kadowaki T, Kashiwagi A, Araki E, Ito C, Inagaki N, Iwamoto Y, Kasuga M, Hanafusa T, Haneda M, Ueki K: Report of the committee on the classification and diagnostic criteria of diabetes mellitus. J Diabetes Investig. 2010, 1: 212-228.PubMedCentralCrossRefPubMed Seino Y, Nanjo K, Tajima N, Kadowaki T, Kashiwagi A, Araki E, Ito C, Inagaki N, Iwamoto Y, Kasuga M, Hanafusa T, Haneda M, Ueki K: Report of the committee on the classification and diagnostic criteria of diabetes mellitus. J Diabetes Investig. 2010, 1: 212-228.PubMedCentralCrossRefPubMed
10.
go back to reference Emoto M, Nishizawa Y, Maekawa K, Hiura Y, Kanda H, Kawagishi T, Shoji T, Okuno Y, Morii H: Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas. Diabetes Care. 1999, 22: 818-822. 10.2337/diacare.22.5.818.CrossRefPubMed Emoto M, Nishizawa Y, Maekawa K, Hiura Y, Kanda H, Kawagishi T, Shoji T, Okuno Y, Morii H: Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas. Diabetes Care. 1999, 22: 818-822. 10.2337/diacare.22.5.818.CrossRefPubMed
11.
go back to reference Emoto M, Kanda H, Shoji T, Kawagishi T, Komatsu M, Mori K, Tahara H, Ishimura E, Inaba M, Okuno Y, Nishizawa Y: Impact of insulin resistance and nephropathy on homocysteine in type 2 diabetes. Diabetes Care. 2001, 24: 533-538. 10.2337/diacare.24.3.533.CrossRefPubMed Emoto M, Kanda H, Shoji T, Kawagishi T, Komatsu M, Mori K, Tahara H, Ishimura E, Inaba M, Okuno Y, Nishizawa Y: Impact of insulin resistance and nephropathy on homocysteine in type 2 diabetes. Diabetes Care. 2001, 24: 533-538. 10.2337/diacare.24.3.533.CrossRefPubMed
12.
go back to reference Wallace TM, Levy JC, Matthews DR: Use and abuse of HOMA modeling. Diabetes Care. 2004, 27: 1487-1495. 10.2337/diacare.27.6.1487.CrossRefPubMed Wallace TM, Levy JC, Matthews DR: Use and abuse of HOMA modeling. Diabetes Care. 2004, 27: 1487-1495. 10.2337/diacare.27.6.1487.CrossRefPubMed
13.
go back to reference Bullo M, Moreno-Navarrete JM, Fernandez-Real JM, Salas-Salvado J: Total and undercarboxylated osteocalcin predict changes in insulin sensitivity and beta cell function in elderly men at high cardiovascular risk. Am J Clin Nutr. 2012, 95: 249-255. 10.3945/ajcn.111.016642.CrossRefPubMed Bullo M, Moreno-Navarrete JM, Fernandez-Real JM, Salas-Salvado J: Total and undercarboxylated osteocalcin predict changes in insulin sensitivity and beta cell function in elderly men at high cardiovascular risk. Am J Clin Nutr. 2012, 95: 249-255. 10.3945/ajcn.111.016642.CrossRefPubMed
14.
go back to reference Kadowaki T, Yamauchi T: Adiponectin and adiponectin receptors. Endocr Rev. 2005, 26: 439-451. 10.1210/er.2005-0005.CrossRefPubMed Kadowaki T, Yamauchi T: Adiponectin and adiponectin receptors. Endocr Rev. 2005, 26: 439-451. 10.1210/er.2005-0005.CrossRefPubMed
Metadata
Title
Undercarboxylated osteocalcin does not correlate with insulin resistance as assessed by euglycemic hyperinsulinemic clamp technique in patients with type 2 diabetes mellitus
Authors
Katsuhito Mori
Masanori Emoto
Koka Motoyama
Eiko Lee
Shinsuke Yamada
Tomoaki Morioka
Yasuo Imanishi
Tetsuo Shoji
Masaaki Inaba
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Diabetology & Metabolic Syndrome / Issue 1/2012
Electronic ISSN: 1758-5996
DOI
https://doi.org/10.1186/1758-5996-4-53

Other articles of this Issue 1/2012

Diabetology & Metabolic Syndrome 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.